UH Researchers develop tool to identify risk in metastatic prostate cancer

  • One of the first validated tools to predict before treatment if a patient will have a favorable biochemical response in patients with metastatic hormone-sensitive prostate cancer.
  • By identifying patients who are unlikely to…

Continue Reading